General Catalyst Group Management, LLC
Follow13F filer, CIK 1637946, CAMBRIDGE, MA
General Catalyst Group Management, LLC reported $1,431,392,565 across 11 holdings for the quarter ended 2024-09-30, in a 13F-HR filed 2024-11-06. Its ten largest share positions make up 99.97% of the portfolio.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-24-010430
- Period
- 2024-09-30
- Reported value
- $1.43B
- Holdings
- 11
- Top 10 weight
- 99.97%
- New
- 0
- Sold out
- 0
Largest buys vs the previous quarter
None.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| IOTreduced | -3,000,000 | -$144M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q3 2024
Share positions as resolved from 13F-HR 0000950123-24-010430, largest first. % of portfolio is the value over $1,431,392,565, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| IOTSAMSARA INC | 23,297,056 | $1.12B | 78.32% | -3,000,000 | Timeline | ||
| WRBYWARBY PARKER INC | 5,656,571 | $92.4M | 6.45% | 0 | Timeline | ||
| GTLBGITLAB INC | 921,405 | $47.5M | 3.32% | 0 | Timeline | ||
| OSCROSCAR HEALTH INC | 2,107,719 | $44.7M | 3.12% | 0 | Timeline | ||
| EVLVEVOLV TECHNOLOGIES HLDNGS IN | 10,796,148 | $43.7M | 3.05% | 0 | Timeline | ||
| AVBPARRIVENT BIOPHARMA INC | 1,494,786 | $35.1M | 2.45% | 0 | Timeline | ||
| CARTMAPLEBEAR INC | 710,711 | $29M | 2.02% | 0 | Timeline | ||
| CMRCCOMMERCE.COM INC | 1,200,000 | $7.02M | 0.49% | 0 | Timeline | ||
| WAG GROUP CO COMMON STOCKWAG GROUP CO COMMON STOCK | 6,976,530 | $6M | 0.42% | 0 | |||
| RDDTREDDIT INC | 69,615 | $4.59M | 0.32% | 0 | Timeline | ||
| VROOM INCVROOM INC | 38,145 | $357K | 0.02% | 0 |
How Q3 2024 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000950123-24-010430 | base | 2024-11-06 | acceptance time not in the bulk data set |